biomarker testing Posts on Medivizor
Navigation Menu

biomarker testing Posts on Medivizor

Biomarkers, Combination Therapy, and Lung Cancer

Biomarkers, Combination Therapy, and Lung Cancer

Posted by on Aug 31, 2022 in Blog, Lung cancer |

KRAS, one gene present in some cancers, was considered “undruggable” for years.[1] Mutated KRAS is an important target for patients with non-small cell lung cancer (NSCLC) because it’s present in 20-25% of cases.[2]  Finally, one drug, sotorasib (Lumakras), is approved to treat one mutant form of KRAS gene, KRAS G12C.[3] This mutation appears in...

Read More